Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang Huahai Pharmaceutical Co., Ltd.

Zhejiang Huahai Pharmaceutical Co., Ltd.

600521

株式のランク #4339
Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical... Zhejiang Huahai Pharmaceutical Co., Ltd. is a China-based pharmaceutical enterprise with a global presence. Its diverse portfolio encompasses treatments for central nervous system disorders, cardiovascular conditions, and viral infections, among other finished pharmaceutical products. Beyond finished drugs, the company also produces Active Pharmaceutical Ingredients (APIs) and crucial intermediates. Huahai Pharmaceutical further engages in the manufacturing of packaging components, notably high-density polyethylene (HDPE) bottles and polypropylene (PP) caps. Additionally, it offers contract manufacturing (CMO) and other specialized services, while also playing a role in import and export trade services. Established in 1989, the company maintains its headquarters in Linhai, China.
株価
$2.42
時価総額
$3.62B
変化(1日)
-0.24%
変化(1年)
-10.04%
国
CN
取引 Zhejiang Huahai Pharmaceutical Co., Ltd. (600521)

カテゴリー

Healthcare
Zhejiang Huahai Pharmaceutical Co., Ltd.(600521)の利益
Jun 2026 時点の利益 TTM: $116.37M
Zhejiang Huahai Pharmaceutical Co., Ltd. の最新の財務報告によると、同社の現在の利益は $116.37M です。2023 年には $155.44M の利益を上げ、これは 2022 年の利益 $218.75M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Zhejiang Huahai Pharmaceutical Co., Ltd. の利益の推移(2000 〜 2026)
各年末の利益
年 利益 変化
2026 (TTM) $116.37M -41.96%
2024 $200.52M 29.00%
2023 $155.44M -28.94%
2022 $218.75M 76.68%
2021 $123.81M -33.45%
2020 $186.04M 70.26%
2019 $109.27M 378.00%
2018 $22.86M -80.91%
2017 $119.77M 46.64%
2016 $81.68M 1.26%
2015 $80.66M 59.65%
2014 $50.52M -25.67%
2013 $67.97M 5.47%
2012 $64.44M 48.73%
2011 $43.33M 123.78%
2010 $19.36M -32.37%
2009 $28.63M 16.51%
2008 $24.57M -5.07%
2007 $25.88M 35.84%
2006 $19.05M -12.70%
2005 $21.83M 10.70%
2004 $19.72M 36.00%
2003 $14.50M 63.58%
2002 $8.86M 36.52%
2001 $6.49M 2.99%
2000 $6.30M 0.00%